Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Carlquist

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Thrombosis and Haemostasis|February 1, 2013
Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genesJohn F Carlquist, Stacey Knight, Benjamin D Horne, et al.
The American Journal of Cardiology|September 5, 2002
Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery diseaseJeffrey L Anderson, Benjamin D Horne, John F Carlquist, et al.
Annals of Human Genetics|August 27, 2009
Validation study of genetic associations with coronary artery disease on chromosome 3q13-21 and potential effect modification by smokingBenjamin D Horne, Elizabeth R Hauser, Liyong Wang, et al.
American Heart Journal|August 2, 2003
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary interventionJoseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, et al.
Cardiology|August 30, 2007
Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiographyMatthew T Rondina, Jason M Lappé, John F Carlquist, et al.
The American Journal of Cardiology|January 16, 2007
Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular diseaseJeffrey L Anderson, Brianna S Ronnow, Benjamin D Horne, et al.
The American Journal of Cardiology|September 22, 2010
Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare populationJeffrey L Anderson, Heidi T May, Benjamin D Horne, et al.
Journal of the American College of Cardiology|November 26, 2002
Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patientsChloe A Allen Maycock, Joseph B Muhlestein, Benjamin D Horne, et al.
Nutrients|January 26, 2019
Pilot Study of Novel Intermittent Fasting Effects on Metabolomic and Trimethylamine <i>N</i>-oxide Changes During 24-hour Water-Only Fasting in the FEELGOOD TrialRachel L Washburn, James E Cox, Joseph B Muhlestein, et al.
The American Journal of Cardiology|June 6, 2013
Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery diseaseJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Thrombosis and Haemostasis|February 1, 2013
Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genesJohn F Carlquist, Stacey Knight, Benjamin D Horne, et al.
The American Journal of Cardiology|September 5, 2002
Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery diseaseJeffrey L Anderson, Benjamin D Horne, John F Carlquist, et al.
Annals of Human Genetics|August 27, 2009
Validation study of genetic associations with coronary artery disease on chromosome 3q13-21 and potential effect modification by smokingBenjamin D Horne, Elizabeth R Hauser, Liyong Wang, et al.
American Heart Journal|August 2, 2003
Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary interventionJoseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, et al.
Cardiology|August 30, 2007
Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiographyMatthew T Rondina, Jason M Lappé, John F Carlquist, et al.
The American Journal of Cardiology|January 16, 2007
Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular diseaseJeffrey L Anderson, Brianna S Ronnow, Benjamin D Horne, et al.
The American Journal of Cardiology|September 22, 2010
Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare populationJeffrey L Anderson, Heidi T May, Benjamin D Horne, et al.
Journal of the American College of Cardiology|November 26, 2002
Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patientsChloe A Allen Maycock, Joseph B Muhlestein, Benjamin D Horne, et al.
Nutrients|January 26, 2019
Pilot Study of Novel Intermittent Fasting Effects on Metabolomic and Trimethylamine <i>N</i>-oxide Changes During 24-hour Water-Only Fasting in the FEELGOOD TrialRachel L Washburn, James E Cox, Joseph B Muhlestein, et al.
The American Journal of Cardiology|June 6, 2013
Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery diseaseJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
Pageof 9